| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 10 | +60.00% | -5.16% | +0.02% | -5.18% | -4.65% | — |
| 14d | 10 | +60.00% | -9.50% | -0.42% | -9.08% | -13.58% | — |
| 30d | 10 | +70.00% | -3.02% | -1.51% | -1.51% | -0.94% | — |
| 60d | 10 | +60.00% | +6.38% | +1.29% | +5.10% | +10.26% | — |
| 90d | 10 | +70.00% | -5.25% | -0.08% | -5.17% | -15.07% | — |
| 180d | 10 | +40.00% | -12.04% | +7.36% | -19.40% | -22.93% | — |
| 1y | 10 | +50.00% | -31.20% | +14.21% | -45.41% | -53.05% | — |
| 2y | 10(7 pending) | +66.67% | +75.51% | +41.03% | +34.48% | +83.34% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| CADL CANDEL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 629,000 | — | — | 629,000 | Jan 26, 2026 | Jan 28, 2026 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 42,826 | $4.67 | $200.0K | 268,566 | Jun 25, 2025 | Jun 26, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 400 | $9.00 | $3.6K | 225,740 | Mar 19, 2025 | Mar 20, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 25,772 | $8.77 | $226.0K | 226,140 | Mar 18, 2025 | Mar 20, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 525,000 | — | — | 525,000 | Feb 12, 2025 | Feb 14, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE Chief Executive Officer | 21,704 | $7.23 | $156.8K | 251,912 | Jan 15, 2025 | Jan 17, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE Chief Executive Officer | 21,172 | $8.22 | $174.0K | 273,616 | Jan 8, 2025 | Jan 10, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE Chief Executive Officer | 48,847 | $4.56 | $222.5K | 294,788 | Nov 29, 2024 | Dec 3, 2024 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 12,900 | $1.55 | $20.0K | 343,635 | Nov 21, 2024 | Nov 21, 2024 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE Chief Executive Officer | 12,900 | — | — | 1,763,968 | Nov 21, 2024 | Nov 21, 2024 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE Chief Executive Officer | 22,528 | $6.47 | $145.8K | 330,735 | Jul 17, 2024 | Jul 19, 2024 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE Chief Executive Officer | 20,293 | $5.97 | $121.2K | 353,263 | Jul 11, 2024 | Jul 15, 2024 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE Chief Executive Officer | 43,443 | $0.90 | $39.1K | 373,556 | Nov 28, 2023 | Nov 30, 2023 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 180,108 | — | — | 416,999 | Nov 26, 2023 | Nov 28, 2023 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 180,000 | — | — | 180,000 | Apr 28, 2023 | May 2, 2023 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 12,935 | $1.92 | $24.8K | 40,985 | Dec 9, 2022 | Dec 12, 2022 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 3,050 | $1.70 | $5.2K | 28,050 | Dec 8, 2022 | Dec 12, 2022 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 195,906 | — | — | 220,906 | Nov 28, 2022 | Nov 30, 2022 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 330,000 | — | — | 330,000 | Feb 28, 2022 | Mar 1, 2022 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 25,000 | $8.00 | $200.0K | 25,000 | Jul 29, 2021 | Aug 2, 2021 ↗ | View → |